Evidence map›Paper›PMID 23831350›Full record

ArticleNeuroscience letters2013

Differential regulation of SC1/PRDM4 and PRMT5 mediated protein arginine methylation by the nerve growth factor and the epidermal growth factor in PC12 cells.

Alexandra Chittka

Open access · hybridAbstract read
In one paragraph

Article in Neuroscience letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Neuronal Differentiation and Outgrowth Effect of Thymol inInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alexandra ChittkaWolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, United Kingdom. a.chittka@ucl.ac.uk
University College London · GB

Funding

Wellcome Trust 076656MA
6 · The paper itself

Abstract

During neuronal development, the neuroepithelial stem cells (NSCs) initially undergo proliferative divisions, later switching to neurogenic ones whereby one NSC and a post-mitotic neuron are generated. We recently showed that a member of the PRDM family of transcriptional regulators, PRDM4/SC1, recruits a type II protein arginine methyltransferase, PRMT5, to maintain the "stem-like" cellular state of the embryonic mouse cortical NSCs. However, little is known about the regulation of activity of this complex under proliferation- or differentiation-inducing growth conditions. In the present work I investigate the regulation of SC1/PRMT5-mediated methylation activity in PC12 cells treated with EGF or NGF. I present evidence that NGF down-regulates SC1/PRMT5 methyltransferase (MTase) activity and that the reduction in SC1/PRMT5 MTase activity occurs mainly in the nucleus. I suggest that high levels of SC1/PRMT5 activity are associated with the proliferative state of the cells.

Indexed as

AnimalsArginineCell ProliferationCells, CulturedDNA-Binding ProteinsDown-RegulationEpidermal Growth FactorMethylationMiceNerve Growth FactorNeuronsPC12 CellsProtein MethyltransferasesRatsTranscription FactorsArginineDNA-Binding ProteinsEpidermal Growth FactorNerve Growth FactorPrdm4 protein, ratProtein MethyltransferasesTranscription FactorsEGFepidermal growth factorHistone arginine methylation(histone) methyltransferase(H)MTasenerve growth factorneural stem cellsNGFNSCPC12 cellspositive regulatory domain proteinPRDMPRDM4PRMTPRMT5protein arginine methyltransferaseSC1Schwann cell factor 1

Identifiers

PMID23831350
PMCPMC3776221
OpenAlexW2039367521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.